Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$62.99
+1.4%
$55.05
$38.91
$147.03
$1.82B0.7469,120 shs425,705 shs
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$80.67
+0.2%
$91.88
$78.27
$118.01
$1.84B0.5330,265 shs167,361 shs
Omnicell, Inc. stock logo
OMCL
Omnicell
$34.37
-1.3%
$39.34
$29.06
$55.00
$1.56B0.97672,915 shs873,104 shs
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
$21.87
-0.6%
$27.02
$13.14
$37.77
$495.41M0.8421,084 shs197,928 shs
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
0.00%+2.44%+6.92%+52.54%-26.43%
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
0.00%+0.27%-0.19%-14.62%-14.69%
Omnicell, Inc. stock logo
OMCL
Omnicell
0.00%+3.90%-4.95%-20.07%+4.72%
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
0.00%-5.57%-24.22%-13.90%+65.18%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$62.99
+1.4%
$55.05
$38.91
$147.03
$1.82B0.7469,120 shs425,705 shs
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$80.67
+0.2%
$91.88
$78.27
$118.01
$1.84B0.5330,265 shs167,361 shs
Omnicell, Inc. stock logo
OMCL
Omnicell
$34.37
-1.3%
$39.34
$29.06
$55.00
$1.56B0.97672,915 shs873,104 shs
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
$21.87
-0.6%
$27.02
$13.14
$37.77
$495.41M0.8421,084 shs197,928 shs
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
0.00%+2.44%+6.92%+52.54%-26.43%
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
0.00%+0.27%-0.19%-14.62%-14.69%
Omnicell, Inc. stock logo
OMCL
Omnicell
0.00%+3.90%-4.95%-20.07%+4.72%
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
0.00%-5.57%-24.22%-13.90%+65.18%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
2.21
Hold$66.195.08% Upside
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
2.33
Hold$110.6037.10% Upside
Omnicell, Inc. stock logo
OMCL
Omnicell
2.67
Moderate Buy$57.8668.34% Upside
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
2.67
Moderate Buy$38.4075.58% Upside

Current Analyst Ratings Breakdown

Latest TCMD, LMAT, INSP, and OMCL Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/4/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
DowngradeSell (D+)Sell (D)
8/31/2026
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
DowngradeHold (C+)Hold (C)
8/24/2026
Omnicell, Inc. stock logo
OMCL
Omnicell
Reiterated RatingOverweight
8/19/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
UpgradeSell (D)Sell (D+)
8/18/2026
Omnicell, Inc. stock logo
OMCL
Omnicell
UpgradeHold (C-)Hold (C)
8/17/2026
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
UpgradeHold (C-)Hold (C+)
8/17/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
UpgradeHoldStrong-Buy
8/14/2026
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
DowngradeBuy (B-)Hold (C+)
8/11/2026
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
Lower Price TargetBuy$40.00 ➝ $39.00
8/7/2026
Omnicell, Inc. stock logo
OMCL
Omnicell
DowngradeHoldStrong Sell
8/5/2026
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
Lower Price TargetEqual Weight$104.00 ➝ $94.00
(Data available from 9/6/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$911.98M2.00$2.86 per share22.03$26.88 per share2.34
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$249.60M7.39$2.90 per share27.80$17.35 per share4.65
Omnicell, Inc. stock logo
OMCL
Omnicell
$1.18B1.32$2.77 per share12.43$27.45 per share1.25
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
$329.52M1.50$1.15 per share18.99$9.80 per share2.23
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$145.42M$4.6213.6341.444.7915.03%8.64%7.45%11/2/2026 (Estimated)
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$57.73M$2.8528.3125.452.3325.02%15.63%10.06%11/5/2026 (Estimated)
Omnicell, Inc. stock logo
OMCL
Omnicell
$2.05M$0.8440.9233.370.863.13%5.66%3.57%10/29/2026 (Estimated)
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
$19.09M$1.0820.2516.20N/A7.10%11.49%9.17%11/2/2026 (Estimated)

Latest TCMD, LMAT, INSP, and OMCL Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/10/2026Q2 2026
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
$0.1350$0.34+$0.2050$0.34$85.52 million$85.70 million
8/4/2026Q2 2026
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$0.8070$0.74-$0.0670$0.74$71.47 million$70.38 million
8/3/2026Q2 2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
-$0.2359$0.14+$0.3759$0.01$194.72 million$200.58 million
7/30/2026Q2 2026
Omnicell, Inc. stock logo
OMCL
Omnicell
$0.4675$0.94+$0.4725$0.52$310.21 million$312.21 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
N/AN/AN/AN/AN/A
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$1.001.24%+16.05%35.09%14 Years
Omnicell, Inc. stock logo
OMCL
Omnicell
N/AN/AN/AN/AN/A
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
N/AN/AN/AN/AN/A

Latest TCMD, LMAT, INSP, and OMCL Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/28/2026
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
quarterly$0.251.21%8/20/20268/20/20269/3/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
N/A
8.55
6.16
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
0.40
16.31
13.96
Omnicell, Inc. stock logo
OMCL
Omnicell
0.13
1.64
1.43
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
N/A
4.12
3.68

Institutional Ownership

CompanyInstitutional Ownership
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
94.91%
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
84.64%
Omnicell, Inc. stock logo
OMCL
Omnicell
97.70%
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
83.43%

Insider Ownership

CompanyInsider Ownership
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
2.20%
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
7.40%
Omnicell, Inc. stock logo
OMCL
Omnicell
2.92%
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
2.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
1,33328.91 million28.27 millionOptionable
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
49022.87 million21.18 millionOptionable
Omnicell, Inc. stock logo
OMCL
Omnicell
3,58045.48 million44.15 millionOptionable
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
1,08622.65 million22.18 millionOptionable

Recent News About These Companies

Tactile Systems Technology Q2 Earnings Call Highlights

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Inspire Medical Systems stock logo

Inspire Medical Systems NYSE:INSP

$62.99 +0.85 (+1.37%)
As of 09/4/2026 03:58 PM Eastern

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

LeMaitre Vascular stock logo

LeMaitre Vascular NASDAQ:LMAT

$80.67 +0.18 (+0.22%)
As of 09/4/2026 04:00 PM Eastern

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature. The company also provides artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches, used for closure of vessels after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; cardiovascular patches; carotid shunts that temporarily shunt the blood to the brain during the removal of plaque in a carotid endarterectomy surgery; biosynthetic vascular graft indicated for lower extremity bypass and dialysis access; and vascular grafts used to bypass or replace diseased arteries. In addition, it offers radiopaque tape, a medical-grade tape applied to the skin that enables surgeons and interventionalists to cross-refer between the inside and the outside of a patient's body and allows them to locate tributaries or lesions beneath the skin. Further, the company provides valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.

Omnicell stock logo

Omnicell NASDAQ:OMCL

$34.37 -0.45 (-1.29%)
As of 09/4/2026 04:00 PM Eastern

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.

Tactile Systems Technology stock logo

Tactile Systems Technology NASDAQ:TCMD

$21.87 -0.14 (-0.64%)
As of 09/4/2026 04:00 PM Eastern

Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.